Bhatia D S, Money S R, Ochsner J L, Crockett D E, Chatman D, Dharamsey S A, Mulingtapang R F, Shaw D, Ramee S R
Department of Surgery, Alton Ochsner Medical Foundation, New Orleans, La, USA.
Ann Vasc Surg. 1996 Sep;10(5):452-5. doi: 10.1007/BF02000591.
Central venous stenosis and occlusion are complications that are being observed with increasing frequency as a result of the use of long-term central venous catheters. These complications are especially problematic in patients with end-stage renal disease and functioning ipsilateral arteriovenous (AV) grafts or fistulas (AV grafts). We have previously demonstrated that the 1-year patency rate for simple balloon angioplasty in these patients is less than 10%. To compare the results of surgical treatment vs. percutaneous dilatation with stent placement, we undertook this retrospective study. All patients underwent multiple central venous catheter placements and had functioning ipsilateral AV grafts. Twenty-six patients were divided into two groups. The surgical treatment group included 13 patients: 10 with subclavian vein thrombosis and three with innominate vein thrombosis. All patients in the surgical group had arm swelling and edema. Surgical bypass procedures were performed in these patients using either polytetrafluoroethylene or saphenous vein. The stent group also included 13 patients; all of them had a diagnosis of subclavian or innominate vein obstruction and were treated with percutaneous transluminal angioplasty and placement of either a self-expanding rigid stent (n = 6) or a balloon-expandable flexible stent (n = 7). Two patients required multiple stent placements. No significant complications occurred in either group. The 1-year mortality rate in both groups was 31%. The percentages of patients who were symptom free at 6 and 12 months were also similar in the two groups. We conclude that surgical bypass and percutaneous transluminal angioplasty with stent placement are both efficacious in the treatment of central venous obstruction.
中心静脉狭窄和闭塞是因长期使用中心静脉导管而越来越频繁出现的并发症。这些并发症在终末期肾病且同侧动静脉(AV)移植物或瘘管(AV移植物)功能正常的患者中尤其成问题。我们之前已经证明,这些患者单纯球囊血管成形术的1年通畅率低于10%。为了比较手术治疗与经皮扩张并置入支架的效果,我们进行了这项回顾性研究。所有患者均接受过多次中心静脉导管置入,且同侧AV移植物功能正常。26例患者被分为两组。手术治疗组包括13例患者:10例为锁骨下静脉血栓形成,3例为无名静脉血栓形成。手术组所有患者均有手臂肿胀和水肿。这些患者使用聚四氟乙烯或大隐静脉进行了手术旁路手术。支架组也包括13例患者;他们均被诊断为锁骨下或无名静脉阻塞,并接受了经皮腔内血管成形术,置入了自膨式硬支架(n = 6)或球囊扩张式软支架(n = 7)。2例患者需要多次置入支架。两组均未发生重大并发症。两组的1年死亡率均为31%。两组在6个月和12个月时无症状患者的百分比也相似。我们得出结论,手术旁路和经皮腔内血管成形术并置入支架在治疗中心静脉阻塞方面均有效。